Press Trust of India | Saturday August 29, 2015
The approval by the US FDA for Raloxifene Hydrochloride tablets is for strength of 60 mg, which is bio and therapeutically equivalent to the reference listed drug product (RLD) Evista, 60 mg of Eli Lilly, the company said in a statement.
NDTV | Friday August 28, 2015
Citi says revenues could ramp up meaningfully over next few years and maintains Aurobindo Pharma as their top pick.
Press Trust of India | Thursday August 27, 2015
The company has now a total of 209 ANDA approvals from the USFDA.
Press Trust of India | Thursday August 20, 2015
Aurobindo Pharma on Thursday said it has received approval from the US Food and Drug Administration (FDA) to market a generic version of Prilosec delayed-release capsules, used to treat ulcer, in the American market.
Press Trust of India | Wednesday August 12, 2015
Aurobindo Pharma on Wednesday reported a 4.1 per cent increase in net profit at Rs 432.4 crore for the fiscal first quarter that ended on June 30, 2015.
Press Trust of India | Monday July 27, 2015
It is indicated for the short-term treatment of tachycardia and hypertension that occur during induction and tracheal intubation, during surgery, on emergence from anaesthesia and in the postoperative period, it said.
NDTV | Friday July 24, 2015
TS Anantakrishnan, managing director, Religare Portfolio Managers & Advisors expects the Nifty to consolidate around 8,600-8,800. Making money in stock markets was easy last year, investors will now have to work harder and be stock specific, he said.
Press Trust of India | Thursday July 23, 2015
The list was dominated by Chinese companies as the country took over half of the spots in the coveted list of Asia-Pacific's 50 best and big public companies.
NDTV | Thursday July 23, 2015
Devang Mehta, senior vice president at Anand Rathi Securities says they are not very bullish on the markets at this point in time.
NDTV | Wednesday July 22, 2015
Aurobindo Pharma's Unit 12 is mainly used to manufacture drugs which are exported to US. The unit manufacturers products like Tazobactam and Piperacilin.
Press Trust of India | Friday July 10, 2015
Flecainide Acetate Tablets are an antiarrhythmic agent with an estimated market size of $61 million for the 12 months ending April, according to IMS.
Press Trust of India | Wednesday July 1, 2015
Drug firm Aurobindo Pharma on Wednesday said its chief executive officer (formulations) Arvind Vasudeva has resigned from the company.
Wednesday June 24, 2015
Including today's gain the stock has surged around 14 per cent in last seven trading sessions after the company said that it had received final approval from the US Food & Drug Administration (US FDA) to manufacture and market extended Phenytoin sodium capsules, which is an anti-epileptic drug used for controlling seizures.
Monday June 22, 2015
Aurobindo Pharma on Monday announced receipt of final approval from the US health regulator to manufacture and market its generic versions of Parkinson's disease treatment drug Entacapone tablets and antibiotics Azithromycin in the American market.
Monday June 15, 2015
Aurobindo Pharma has received final approval from the US Food and Drug Administration (FDA) to make and market generic anti-epileptic Phenytoin Sodium capsules in America.
Thomson Reuters | Friday June 12, 2015
The government has scrapped customs import duties for drugs and test kits used to treat AIDS in an effort to cut prices across the country, as it struggles to cope with an ongoing shortage in its national program to fight the disease.
Wednesday June 10, 2015
Elaborating on the capital expenditure plans during the current fiscal, he said the company is continuing to invest in enhancing finished dosage as well as active pharmaceutical ingredient (API) capacity.
Monday June 1, 2015
Aurobindo Pharma has received approval of the US Food and Drug Administration (FDA) to manufacture and market Metronidazole tablets in the American market.
Thursday May 28, 2015
Net sales of the company stood at Rs 3,142.46 crore for the fourth quarter, while the same stood at Rs 2,305.88 crore during the corresponding period of previous year, Aurobindo Pharma said in a filing to the BSE.
Thursday April 16, 2015
The approval by the USFDA is for strengths of 100 mg/5 ml and 200 mg/5 ml and the product is ready for launch, Aurobindo Pharma said in a statement.
Wednesday April 15, 2015
Aurobindo Pharma today said it has got final approval from the US Food and Drug Administration (USFDA) to make and sell its generic version of oral suspension of antibiotic Cefixime.
Friday April 10, 2015
APL will continue to manufacture and supply products to Eris Pharma for Australian and New Zealand markets over the next few years, it added.
Thursday April 9, 2015
Aurobindo Pharma today said Plethico will pay it $23.3 million to settle a dispute related to the acquisition of US-based Natrol.
Wednesday April 8, 2015
Glenmark surged over 6 per cent to hit intraday high of Rs 898. The CCEA had yesterday cleared its proposal to increase foreign holding limit (FII limit) in the company to 49 per cent from 35.07 per cent now.